Skip to main content
Cytek Biosciences, Inc. logo

Cytek Biosciences, Inc. — Investor Relations & Filings

Ticker · CTKB ISIN · US23285D1090 LEI · 549300K2J28BOC6FBO89 US Manufacturing
Filings indexed 412 across all filing types
Latest filing 2022-04-08 Director's Dealing
Country US United States of America
Listing US CTKB

About Cytek Biosciences, Inc.

https://cytekbio.com

Cytek Biosciences, Inc. is a cell analysis solutions company that provides instruments, reagents, and services based on its patented Full Spectrum Profiling (FSP) technology. This technology enables its flow cytometry systems, including the Aurora, Northern Lights, and Muse series, to capture the entire emission spectrum of fluorescent dyes. This allows researchers to conduct high-resolution, high-multiplex experiments, using panels of 40 or more colors from a single sample. By providing more data from precious samples, the technology aims to reduce experimental complexity and cost. Cytek offers a complete solution with its cFluor® reagents, which are optimized for spectral cytometry, alongside software and application support. The company's products are intended to advance biomedical research in fields such as immunology, cancer research, and cell biology.

Recent filings

Filing Released Lang Actions
FORM 4 SUBMISSION
Director's Dealing
2022-04-08 English
FORM 4 SUBMISSION
Director's Dealing
2022-03-23 English
S-8
Regulatory Filings Classification · 100% confidence The document is a Form S-8 Registration Statement filed with the SEC, which is used to register securities to be offered under employee benefit plans such as equity incentive plans and employee stock purchase plans. It includes details about the registration of additional shares under these plans and incorporates by reference other filings like the Annual Report on Form 10-K and Current Reports on Form 8-K. The document is not a financial report, earnings release, or management discussion but a regulatory filing related to securities registration. Therefore, it fits best under the category of Regulatory Filings (RNS).
2022-03-17 English
10-K
Annual Report FY 2021
2022-03-17 English
OWNERSHIP DOCUMENT
Director's Dealing
2022-03-16 English
CYTEK BIOSCIENCES, INC.
Major Shareholding Notification
2022-03-14 English

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.